EUROPASS CURRICULUM VITAE

Transcription

1 EUROPASS CURRICULUM VITAE PERSONAL INFORMATION name address privat address work Univ. Prof. Dr. Gabriele Fischer Kochgasse 3-5/12a, 1080 Wien, Austria Medical University of Vienna Center for Public Health Department of Psychiatry & Psychotherapy Währinger Gürtel 18-20, 1090 Vienna, Austria phone fax home page nationality date of birth gabriele.fischer@meduniwien.ac.at Austria WORK EXPERIENCE since 01.July 2015 Austrian Ombudsman Board Commission Director since 2013 European Monitoring Center for Drugs and Drug Addiction (EMCDDA) Member of scientific board since 2011 Center for Public Health Medical University Vienna Kinderspitalgasse 15, 1090 Vienna Project Leader Addiction in Public Health since Department of Psychiatry & Psychotherapy, Medical University of Vienna Spitalgasse 23, 1080 Vienna Professor for Psychiatry Addiction Research and Treatment Medical Director of Addiction Clinic since 2000 Austrian Federal Ministry of Health Austrian Medical Advisory Council Member since 2000 UNODOC and WHO Consultant Seite 1 Lebenslauf von

2 from 1992 to 2000 Head of Units from to Co-director: Intensive care Unit (emergency) from to Director: Forensic Addiction Clinic from to Co-Director: Behavioural Therapy Unit since 1991 Licenced Specialist as Psychiatrist & Neurologist from 1986 to 1990 Residency in Psychiatry from Department of Neurology, Medical University of Vienna Residency in Neurology from 1987 to 1989 Washington University, Department of Psychiatry, St. Louis, USA Visiting fellow, research education in epidemiology, basic neuroscience & statistics with a focus in addiction psychiatry & personality disorders from to II. Internal Medical University Clinic, Vienna Residency in Internal Medicine from to Department of Child and Adolescent Psychiatry, Medical University of Vienna Residency in Adolescent Psychiatry EDUCATION AND TRAINING Habilitation Subject: Addiction research and therapy University of Vienna Graduation in hospital management and administration from 1996 to 1998 since from 1986 to 1992 since 1991 from 1989 to 1990 from 1987 to 1989 University of Vienna Post gradual education in hospital management and administration Licenced medical specialist for Intensive Care Psychotherapeutic education in Behavioural Therapy Licenced specialist as Psychiatrist & Neurologist Residency in Psychiatry Washington University, Department of Psychiatry/Jewish hospital Medical School of St. Louis USA Visiting fellow; Research education in epidemiology basic neuroscience & statistics with focus in addiction psychiatry & gender/sex aspects Seite 2 Lebenslauf von

3 from 1984 to 1986 Residency in Psychiatry University of Vienna Promotion Dr. med. Univ. Medical Degree from 1978 to 1984 University of Vienna, Medical Department Student 1978 High school Wels General qualification for university access from 1974 to 1978 from 1970 to 1974 from 1966 to 1970 High school Wels Student High school Stainach Student Elementary school Student PERSONAL SKILLS MOTHER TONGUE GERMAN OTHER LANGUAGES understanding reading speaking ENGLISH excellent excellent excellent understanding reading speaking French Good adequate adequate ORGANISATIONAL & MANAGERIAL SKILLS since 2011 MINI MED Studies Board member since 1995 Organisation of training courses, meetings, workshops and conferences (Annex 3) from 2013 to 2015 from 2008 to 2013 from 2003 to 2013 from 2007 to 2010 from 1994 to 2003 Austrian Federal Ministry of Justice Task force of minister: imprisonment on remand for youth: prevention-reduction-execution Medical University of Innsbruck Chair of University Board of Trustees Medical University of Innsbruck Member of University Board of Trustees Austrian Society for Gender Medicine Board member University of Vienna, Medical faculty Member of the committee for gender equality Seite 3 Lebenslauf von

4 COMMUNICATION SKILLS since 1990 since 1985 since 1985 COMPUTER SKILLS Medical University of Vienna Lecturer (Betrauungsdekret) Diagnostic und Therapy of addictive disorders Psychiatric and behavioural disorders related to psychotropic substances under consideration of gender aspects Gender lectures MCW 20 Lectures and presentations at national and international conferences (Annex 2) Scientific publications in national and international peer reviewed journals, book contributions and books (Annex 1) Word Power Point Excel SPSS DRIVING LICENCE Category A and B ADDITIONAL INFORMATIONS AWARDS 2015 NIDA/NIH Award for Excellence in International Research Collaboration 2008 Chimera Award, Sofia, Bulgaria 2007 Chimera Award, Pietrassanta, Italy 2000 CNS Research Award, Austrian Society for Neurology and Psychiatry, Supreme Award (founded by Pfizer) 1998 University Vienna Award, Women s Forum MEMBERSHIP Scientific Associations CPDD College on Problems of Drug Dependence ECNP European College of Neuropsychopharmacology European Methadone Association EPA-gender section: gender differences and substance use disorder IDHDP International Doctors of Healthy Drug Policies ISAM International Society of Addiction Medicine NEAR Network of Excellence in Addiction Research ÖGPP Austrian Society for Psychiatry & Psychotherapy Society for the Study of Addiction and Alcohol and Other Drugs Seite 4 Lebenslauf von

5 Scientific or Advisory Board Editorial board Senior Editor Associate Editor Assistant Editor Reviewer Member of Austrian Medical Council Scientific advisory board: Addiction und ADHD EUFAS European Federation of Addiction Societies Eureka Eurostars: Advisory board member for EU framework grants UNODOC Technical consultant; treatment implementation for substance dependent women & children in Afghanistan WHO Currently: Development on guidelines for diagnoses and treatment of substance dependence in pregnancy WPA Section on Dual Disorders/Pathology Archives of Women s Mental Health European Addiction Research European Neuropsychopharmacology Frontiers Heroin Addiction and Related Clinical Problems PLOS ONE Psychology of Addictive Behaviors Research Journal of Drug Abuse Suchtmedizin Suchttherapie Wiener Klinische Wochenschrift Addiction Addiction Science & Clinical Practice Frontiers in Pharmacology Addiction Cochrane European Addiction Research Frontiers in Clinical Trials and Pharmacotherapy Addiction Archives of General Psychiatry British Medical Journal Drug and Alcohol Review Drug and Alcohol Dependence European Addiction Research European Journal of Clinical Investigation European Neuropsychopharmacology European Psychiatry International Journal of Psychiatry in Clinical Practice Journal of Psychopharmacology Pharmacopsychiatry Psychiatrie und Psychotherapie SPPE Social Psychiatry and Psychiatric Epidemiology Suchtmedizin in Forschung und Praxis Suchttherapie Wiener Klinische Wochenschrift Wiener Medizinische Wochenschrift And others Seite 5 Lebenslauf von

6 PROJECTS EU Grants 2015 "Taking CAre of Vulnerable females during PErinatality in France Austria Italy and Romania. Erasmus+ project Nr.: FR01-KA " REDUCE Project: Reducing hepatitis C sexual and drug taking risk behaviours among female drug users in Europe: translating evidence into practice. European Commission, Directorate General Justice. EU Contract Nr.: JLS/ /DPIP/AG/ Study on the Development of a EU Framework for minimum quality standards and benchmarks in drug demand reduction. European Commission Directorate General Justice, Liberty and Security EU contract Nr.: JLS 2010/DPIR/PR/ EU Model of good practice in drug treatment in Europe More Treat 6th framework program EU contract Nr.: F Rose Management of high risk opiate addicts 5th framework program EU contract Nr.: QLG4-CT Cocaine cocaine 5th framework program EU Grant Nr.: QLGA-CT NIH Grants Supplement: Developmental investigation on neonates exposed to buprenorphine vs. methadone NIH Grant Nr.: 1R01DA MOTHER Maternal Opioid Treatment: Human Experimental Research; randomised, multicenter, double-blind study to compare Methadone and Buprenorphine for treatment of opioid dependent women during their pregnancy and consequences on Neonatal Abstinence Syndrome (NAS) NIH Grant Nr.: 1R01 DA Open Society Institute August November 2013 Substance abuse during pregnancy: prevention, detection and treatment. Network initiative Funds by Austrian National Bank since 2015 ADHS: Prevalence and comorbidity in high risk population ÖNB Nr.: Pregnancy: Substance-related consequences for fetus and neonates Anniversary Fund ÖNB Nr.: Quality of experience survey of opioid addicted patients in opioid maintenance therapy: Quality of life and mortality rate. ÖNB Nr.: Addiction and pregnancy: Evaluation of health related factors in neonates and their mothers ÖNB Nr.: Brain - SPECT screening for substance dependence ÖNB Nr.: Buprenorphine/Methadone in opioid maintenance therapy ÖNB Nr.: 5818 Seite 6 Lebenslauf von

7 Mayor Funds Buprenorphine opioid maintenance therapy in opioid addicted women Mayor Fund Nr.: Influence of methadone, morphine, buprenorphine and naltrexone on humoral and cellular immune parameters in opioid addicted patients undergoing opioid maintenance therapy in comparison to heroin addicts Mayor Fund Nr.: Morphine maintenance in opioid dependent pregnant women Mayor Fund Nr Other third party funding projects since 2013 since 2011 since 2011 Prevalence of adult attention deficit/hyperactivity disorder and comorbid psychiatric disorders in patients with substance use disorder or problematic gambling as well as non treatment-seeking gamblers. Development of a morphine-naloxone combination tablet: Phase II single centre double blinded cross over dose confirmation study using two morphine-naloxone intravenous solutions Lifestyle survey with particular focus on eating behaviour in students 2008 Prevalence of substance use disorder in pathological gambling A randomized open label, multicenter, efficacy and safety study examining the effects of 24 versus 48 weeks of combination therapy with Pegasys Peginterferon Alfa-2a 40 KD plus Copegus (Ribavarin) on Sustained virological response in patients with chronic Hepatitis C, Genotyp 2 or 3 who do not achieve a rapid viral response. (RO und RO ) Evaluation of switching opioid dependent patients to Suboxone R. Acceptance, safety and consequences for medication (PO 5444) 2008 Vienna research festival Addiction-parcours Prevalence of addictive disorders with focus on non-substance related dependence: sex/gender aspects and comorbidity Hepatitis C Genotyp 2/3 study ML17087; Randomised, multicentre study to compare efficiency of pegylised interferon ALFA 2A (Peg-INF 2A) in combination with two different doses of Ribavirin in patients with chronic Hepatitis C Subtyp 2/ Quality assurance in the implementation of slow release oral morphine for treatment of opioid dependence and involvement of general practitioners Webportal substance use disorder international comparison Application of morphine with particular focus on interdisciplinary cooperation with general practitioners Educational Grants for production of various brochures and guidelines Controlled application of buprenorphine with particular focus on gender aspects (Cooperation with general practitioners) Seite 7 Lebenslauf von 2001 Controlled application of buprenorphine with particular focus on incorporation of general practitioners Application of slow release oral morphine with particular focus on introduction.

8 2000 Application of slow release oral morphine in opioid addicted patients Comparison of efficiency and tolerance of morphinsulfate Retardgranulat versus Methadone (daily oral dosage) ANNEXES 1 Publications 2 Lectures 3 Organisation of meetings, training courses, workshops Wien, am Seite 8 Lebenslauf von